352 related articles for article (PubMed ID: 24910342)
1. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.
Murase R; Kawamura R; Singer E; Pakdel A; Sarma P; Judkins J; Elwakeel E; Dayal S; Martinez-Martinez E; Amere M; Gujjar R; Mahadevan A; Desprez PY; McAllister SD
Br J Pharmacol; 2014 Oct; 171(19):4464-77. PubMed ID: 24910342
[TBL] [Abstract][Full Text] [Related]
2. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.
McAllister SD; Murase R; Christian RT; Lau D; Zielinski AJ; Allison J; Almanza C; Pakdel A; Lee J; Limbad C; Liu Y; Debs RJ; Moore DH; Desprez PY
Breast Cancer Res Treat; 2011 Aug; 129(1):37-47. PubMed ID: 20859676
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD
Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.
Berg BB; Soares JS; Paiva IR; Rezende BM; Rachid MA; Cau SBA; Romero TRL; Pinho V; Teixeira MM; Castor MGME
J Pharmacol Exp Ther; 2021 May; 377(2):273-283. PubMed ID: 33658314
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
9. Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.
Murase R; Sumida T; Kawamura R; Onishi-Ishikawa A; Hamakawa H; McAllister SD; Desprez PY
Cancer Lett; 2016 Jul; 377(1):11-6. PubMed ID: 27087608
[TBL] [Abstract][Full Text] [Related]
10. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
11. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
12. Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
[TBL] [Abstract][Full Text] [Related]
13. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK
PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
Shrivastava A; Kuzontkoski PM; Groopman JE; Prasad A
Mol Cancer Ther; 2011 Jul; 10(7):1161-72. PubMed ID: 21566064
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.
McAllister SD; Christian RT; Horowitz MP; Garcia A; Desprez PY
Mol Cancer Ther; 2007 Nov; 6(11):2921-7. PubMed ID: 18025276
[TBL] [Abstract][Full Text] [Related]
18. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
Qiao Z; Kumar A; Kumar P; Song ZH
Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
Massi P; Vaccani A; Ceruti S; Colombo A; Abbracchio MP; Parolaro D
J Pharmacol Exp Ther; 2004 Mar; 308(3):838-45. PubMed ID: 14617682
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids and standardized cannabis extracts inhibit migration, invasion, and induce apoptosis in MCF-7 cells through FAK/MAPK/Akt/NF-κB signaling.
Suttithumsatid W; Sukketsiri W; Panichayupakaranant P
Toxicol In Vitro; 2023 Dec; 93():105667. PubMed ID: 37625625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
